# Navan, Inc.

Type: Company (NAVN)

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/navan-inc
Canonical HTML page: https://getbiobrief.com/entity/navan-inc

## Timeline

- **2026-Q3**: Motion to Dismiss Phase — Defendants expected to file motions to dismiss based on Safe Harbor protections for forward-looking statements.
- **2026-04-15**: Lead Plaintiff Deadline (Est.) — Typical 60-day window for investors to petition the court to lead the consolidated class action.
- **2026-03-05**: Investor Alerts Issued — Pomerantz Law Firm releases multiple reminders for class action deadlines across the biotech sector.

## Recent coverage (1 stories)

### Pomerantz Law Firm Issues Class Action Deadlines for Major Biotech Firms
2026-03-05 23:21:15 · Sentiment: Neutral · Impact: 5/10 · Sources: 4

Pomerantz Law Firm has issued urgent reminders to investors regarding class action deadlines for Ultragenyx, Mereo BioPharma, Navan, and Fermi. These legal actions follow allegations of misleading statements and failures to disclose material risks concerning clinical data and financial projections.
Full story: https://getbiobrief.com/story/pomerantz-biotech-class-action-deadlines-2026

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.